IMP
Process View
negative chemotaxis
The directed movement of a motile cell or organism towards a lower concentration of a chemical.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative chemotaxis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.999 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.997 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.982 | ||
| NRP1 | neuropilin 1 | 0.970 | ||
| VEGFA | vascular endothelial growth factor A | 0.911 | Human | |
| TLN1 | talin 1 | 0.762 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.750 | ||
| FN1 | fibronectin 1 | 0.742 | ||
| DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.683 | Fly | |
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.676 | Fly | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.530 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.492 | Human | |
| LRRK2 | leucine-rich repeat kinase 2 | 0.430 | ||
| PLXND1 | plexin D1 | 0.389 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.283 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.272 | ||
| CSNK1E | casein kinase 1, epsilon | 0.270 | ||
| PGF | placental growth factor | 0.259 | Human | |
| HP | haptoglobin | 0.250 | ||
| PXN | paxillin | 0.194 | ||
| TNFAIP1 | tumor necrosis factor, alpha-induced protein 1 (endothelial) | 0.172 | ||
| ENG | endoglin | 0.160 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.157 | ||
| THBS1 | thrombospondin 1 | 0.108 | ||
| PDGFC | platelet derived growth factor C | 0.104 | ||
| APOC1 | apolipoprotein C-I | 0.084 | ||
| A2M | alpha-2-macroglobulin | 0.077 | ||
| CPE | carboxypeptidase E | 0.070 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.069 | ||
| ITGB4 | integrin, beta 4 | 0.064 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.058 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.056 | ||
| CTGF | connective tissue growth factor | 0.056 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.052 | ||
| APOC3 | apolipoprotein C-III | 0.050 | ||
| ALB | albumin | 0.047 | ||
| LDLR | low density lipoprotein receptor | 0.047 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.044 | ||
| CEP164 | centrosomal protein 164kDa | 0.042 | ||
| AXIN1 | axin 1 | 0.042 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.041 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.040 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.034 | ||
| FLNA | filamin A, alpha | 0.033 | ||
| EFNA5 | ephrin-A5 | 0.033 | ||
| RHOA | ras homolog gene family, member A | 0.032 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.031 | ||
| PRPF3 | PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae) | 0.030 | ||
| ZNF512B | zinc finger protein 512B | 0.030 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.029 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.028 | ||
| WT1 | Wilms tumor 1 | 0.028 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.027 | ||
| STC1 | stanniocalcin 1 | 0.027 | ||
| ADAM9 | ADAM metallopeptidase domain 9 | 0.026 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.025 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.024 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.024 | ||
| MCC | mutated in colorectal cancers | 0.023 | ||
| ROCK1 | Rho-associated, coiled-coil containing protein kinase 1 | 0.023 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.022 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.022 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.021 | ||
| JAG1 | jagged 1 | 0.020 | ||
| APOA2 | apolipoprotein A-II | 0.020 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.020 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.018 | ||
| FHL2 | four and a half LIM domains 2 | 0.016 | ||
| ITGB5 | integrin, beta 5 | 0.015 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.015 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.015 | ||
| CHERP | calcium homeostasis endoplasmic reticulum protein | 0.015 | ||
| PLEC | plectin | 0.015 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.014 | ||
| RHOC | ras homolog gene family, member C | 0.014 | Human | |
| CD9 | CD9 molecule | 0.013 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.013 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.013 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.012 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.012 | ||
| BAHD1 | bromo adjacent homology domain containing 1 | 0.012 | ||
| APOA1 | apolipoprotein A-I | 0.012 | ||
| PLXNB2 | plexin B2 | 0.011 | ||
| PRRX1 | paired related homeobox 1 | 0.011 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.011 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.011 | ||
| CSNK1D | casein kinase 1, delta | 0.011 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.011 | ||
| EPHA3 | EPH receptor A3 | 0.011 |